Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Philippe Beuzeboc

Showing results (1-10 of 128) with videos related to

Pageof 13
Sort By:
Soins; La Revue De Reference Infirmiere|April 11, 2007
[Prostate cancer epidemiology]Philippe Beuzeboc,
European Urology|February 2, 2010
Words of wisdom. Re: anti-androgens and androgen-depleting therapies in prostate cancer: new agents for an established targetPhilippe Beuzeboc
European Urology|March 19, 2011
Words of wisdom. Re: Prednisone plus cabazitaxel or mitoxantrone for metastatic castration-resistant prostate cancer progressing after docetaxel treatment: a randomised open-label trialPhilippe Beuzeboc
European Urology|January 15, 2015
Words of wisdom. Re: Rapid induction of androgen receptor splice variants by androgen deprivation in prostate cancerPhilippe Beuzeboc
Bulletin Du Cancer|June 13, 2003
[From San Antonio to Saint-Gallen: reflections of Saint-Paul-de-Venice or how to treat breast cancer]Joseph Gligorov, Philippe Beuzeboc
Progres En Urologie : Journal De L'Association Francaise D'Urologie Et De La Societe Francaise D'Urologie|April 9, 2005
[Androgen replacement therapy and prostate cancer]Philippe Beuzeboc, Pierre Richaud
Bulletin Du Cancer|June 2, 2015
[How to manage patients with CRPC?]Philippe Beuzeboc, Christophe Massard
Bulletin Du Cancer|March 9, 2023
[Drug approval: Olaparib in combination with abiraterone for metastatic castration-resistant prostate cancer]Annabelle Sabouret, Philippe Beuzeboc
Journal of Clinical Medicine|August 4, 2015
Prevention of Bone Metastases in Breast Cancer Patients. Therapeutic PerspectivesPhilippe Beuzeboc, Suzy Scholl
Current Opinion in Oncology|March 30, 2019
Side effects of immunotherapy: a constant challenge for oncologistsFlorian Scotté, Raffaele Ratta, Philippe Beuzeboc
Pageof 13

Showing results (1-10 of 128) with videos related to

Sort By:
Pageof 13
Soins; La Revue De Reference Infirmiere|April 11, 2007
[Prostate cancer epidemiology]Philippe Beuzeboc,
European Urology|February 2, 2010
Words of wisdom. Re: anti-androgens and androgen-depleting therapies in prostate cancer: new agents for an established targetPhilippe Beuzeboc
European Urology|March 19, 2011
Words of wisdom. Re: Prednisone plus cabazitaxel or mitoxantrone for metastatic castration-resistant prostate cancer progressing after docetaxel treatment: a randomised open-label trialPhilippe Beuzeboc
European Urology|January 15, 2015
Words of wisdom. Re: Rapid induction of androgen receptor splice variants by androgen deprivation in prostate cancerPhilippe Beuzeboc
Bulletin Du Cancer|June 13, 2003
[From San Antonio to Saint-Gallen: reflections of Saint-Paul-de-Venice or how to treat breast cancer]Joseph Gligorov, Philippe Beuzeboc
Progres En Urologie : Journal De L'Association Francaise D'Urologie Et De La Societe Francaise D'Urologie|April 9, 2005
[Androgen replacement therapy and prostate cancer]Philippe Beuzeboc, Pierre Richaud
Bulletin Du Cancer|June 2, 2015
[How to manage patients with CRPC?]Philippe Beuzeboc, Christophe Massard
Bulletin Du Cancer|March 9, 2023
[Drug approval: Olaparib in combination with abiraterone for metastatic castration-resistant prostate cancer]Annabelle Sabouret, Philippe Beuzeboc
Journal of Clinical Medicine|August 4, 2015
Prevention of Bone Metastases in Breast Cancer Patients. Therapeutic PerspectivesPhilippe Beuzeboc, Suzy Scholl
Current Opinion in Oncology|March 30, 2019
Side effects of immunotherapy: a constant challenge for oncologistsFlorian Scotté, Raffaele Ratta, Philippe Beuzeboc
Pageof 13